This announcement is a separate document:
Neuroscientific Biopharmaceuticals Ltd: NSB Completes PRE-IND Meeting with US FDA on EmtinB
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.